Compound information
- Natural Products
- ZC61734
- Molecular Formula
- C7H9NO2
- Molecular Weight
- 139.063328528 g/mol
- Structure
-
- IUPAC Name
- 1-propylpyrrole-2,5-dione
- InChI
- InChI=1S/C7H9NO2/c1-2-5-8-6(9)3-4-7(8)10/h3-4H,2,5H2,1H3
- InChI Key
- DABFKTHTXOELJF-UHFFFAOYSA-N
- SMILES
- CCCN1C(=O)C=CC1=O
- Source
- ZINC000001751808
Warheads
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 10 | Ring Count | 1 |
Heteroatom Count | 3 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 37.38 Å2 | LogP | 0.876 |
LogS | -1.777 | LogD | 0.586 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.157 | Pgp substrate | 0.016 |
HIA | 0.964 | F20 % | 0.988 |
F30 % | 0.786 | Caco-2 | -4.611 |
MDCK | -4.479 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.999 | PPB | 83.951 |
VD | 0.941 | Fu | 0.428 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.598 | CYP1A2 substrate | 0.58 |
CYP2A6 substrate | 0.519 | CYP2B6 substrate | 0.5 |
CYP2C19 inhibitor | 0.131 | CYP2C19 substrate | 0.422 |
CYP2C8 substrate | 0.5 | CYP2C9 inhibitor | 0.125 |
CYP2C9 substrate | 0.021 | CYP2D6 inhibitor | 0.019 |
CYP2D6 substrate | 0.104 | CYP2E1 substrate | 0.74 |
CYP3A4 inhibitor | 0.004 | CYP3A4 substrate | 0.26 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.726 | CL | 6.843 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.698 |
Mutagenicity | 0.008 | Rat Oral Acute Toxicity | 0.863 |
FDAMDD | 0.149 | Skin Sensitization | 0.992 |
Carcinogenicity | 0.613 | Eye Corrosion | 0.968 |
Eye Irritation | 0.984 | Respiratory Toxicity | 0.053 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.44 | IGC50 | 3.105 |
LC50FM | 2.672 | LC50DM | 3.518 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.102 | NR-AR-LBD | 0.257 |
NR-AhR | 0.004 | NR-Aromatase | 0.082 |
NR-ER | 0.204 | NR-ER-LBD | 0.382 |
NR-PPAR-gamma | 0.769 | SR-ARE | 0.862 |
SR-ATAD5 | 0.503 | SR-HSE | 0.879 |
SR-MMP | 0.119 | SR-p53 | 0.646 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.